Full Text
PGI5 COSTS BENEFITS WITH ESOMEPRAZOLE 20MG 'ONDEMAND' TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS IN BELGIUM

Abstract

Authors

E Louis D Urbain M Deltenre G Vandenhoven V Duquenne B Schockaert

Back to Volume 7, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×